Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fry

Showing results (61-70 of 201) with videos related to

Pageof 21
Sort By:
Research Communications in Chemical Pathology and Pharmacology|August 1, 1985
The effect of cimetidine on the formation of methoxyflurane fluorometabolites in miceB W Fry, A E Ciarlone, B E Coalson
Seminars in Oncology|November 14, 2001
CI-1033, a pan-erbB tyrosine kinase inhibitorW J Slichenmyer, W L Elliott, D W Fry
Cancer Research|August 1, 1984
Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier systemD W Fry, J A Besserer, T J Boritzki
Pharmacology and Therapeutics in Dentistry|January 1, 1980
Early appearance of methoxyflurane fluorometabolites in miceB W Fry, A E Ciarlone, R E Faircloth
Anesthesiology|January 1, 1973
Fluorometabolites of methoxyflurane: serum concentrations and renal clearancesB W Fry, D R Taves, R G Merin
Protein Expression and Purification|February 1, 1996
Expression, purification and characterization of focal adhesion kinase using a baculovirus systemB E Withers, P R Keller, D W Fry
The Journal of Biological Chemistry|May 10, 1981
Adenosine stimulation of uphill adenine transport in L1210 leukemia cells. Evidence for a novel countertransport mechanismR L Cybulski, D W Fry, I D Goldman
Current Opinion in Oncology|November 25, 1997
Inhibitors of tyrosine kinaseW D Klohs, D W Fry, A J Kraker
Plant Physiology|November 1, 1983
Isolation, purification, and partial characterization of formate dehydrogenase from soybean seedM P Farinelli, D W Fry, K E Richardson
Cancer Chemotherapy and Pharmacology|January 1, 1984
Studies on the biochemical mechanism of the novel antitumor agent, CI-920D W Fry, T J Boritzki, R C Jackson
Pageof 21

Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
Research Communications in Chemical Pathology and Pharmacology|August 1, 1985
The effect of cimetidine on the formation of methoxyflurane fluorometabolites in miceB W Fry, A E Ciarlone, B E Coalson
Seminars in Oncology|November 14, 2001
CI-1033, a pan-erbB tyrosine kinase inhibitorW J Slichenmyer, W L Elliott, D W Fry
Cancer Research|August 1, 1984
Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier systemD W Fry, J A Besserer, T J Boritzki
Pharmacology and Therapeutics in Dentistry|January 1, 1980
Early appearance of methoxyflurane fluorometabolites in miceB W Fry, A E Ciarlone, R E Faircloth
Anesthesiology|January 1, 1973
Fluorometabolites of methoxyflurane: serum concentrations and renal clearancesB W Fry, D R Taves, R G Merin
Protein Expression and Purification|February 1, 1996
Expression, purification and characterization of focal adhesion kinase using a baculovirus systemB E Withers, P R Keller, D W Fry
The Journal of Biological Chemistry|May 10, 1981
Adenosine stimulation of uphill adenine transport in L1210 leukemia cells. Evidence for a novel countertransport mechanismR L Cybulski, D W Fry, I D Goldman
Current Opinion in Oncology|November 25, 1997
Inhibitors of tyrosine kinaseW D Klohs, D W Fry, A J Kraker
Plant Physiology|November 1, 1983
Isolation, purification, and partial characterization of formate dehydrogenase from soybean seedM P Farinelli, D W Fry, K E Richardson
Cancer Chemotherapy and Pharmacology|January 1, 1984
Studies on the biochemical mechanism of the novel antitumor agent, CI-920D W Fry, T J Boritzki, R C Jackson
Pageof 21